3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
4
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
toripalimab
2
zanidatamab
1
tislelizumab
1
disitamab vedotin
1
Probiotics
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Muscle Invasive Bladder Cancer (MIBC)
×
zanidatamab
×
Clear all
NCT07296705
2025-12-22
HARBOR
Fujian Medical University Union Hospital
Phase 2
Recruiting
25 enrolled